title: Timing of rectal cancer surgery following neoadjuvant chemoradiation: how close are we to striking an equipoise?
authors.affiliation: Hepatobiliary & Oesophagogastric Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia.
authors.forename: Savio George
authors.initials: SG
authors.lastname: Barreto
authors.affiliation: Department of Medical Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
authors.forename: Bhawna
authors.initials: B
authors.lastname: Sirohi
authors.affiliation: Department of Gastrointestinal & Hepato-Pancreato-Biliary Surgical Oncology, Tata Memorial Centre, Parel, Mumbai, India.
authors.forename: Shailesh V
authors.initials: SV
authors.lastname: Shrikhande
mesh_terms: D059248:Chemoradiotherapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D019468:Disease Management; D006801:Humans; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D061665:Time-to-Treatment; D016896:Treatment Outcome
keywords: MRI; fibrosis; meta-analysis; morbidity; mortality; outcomes; pathology; randomized controlled trial; research; survival